By increasing the lysosome number and deacetylating lysosome-related proteins [5], SIRT1 also promotes β-amyloid peptide (Aβ) degradation in primary astrocytes, which is beneficial in Alzheimer’s disease. Here, SIRT1 is linked to early-onset autosomal dominant Alzheimer disease.